Please assess the completion status of the following clinical trial:

Trial Title: Alvimopan as Rescue in Post op Ileus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subjects who have benign or malignant colonic or rectal disease that have undergone laparoscopic or open colorectal resection, small bowel resection or ileostomy reversal with small bowel resection and subsequently developed postoperative ileus, defined as:~   * Return to NPO status after initial diet attempts, or~  * Placement of nasogastric tube~2. Subjects who are 18 years of age and older~3. Subjects of either gender~4. Subjects who are willing and able to adhere to protocol requirements, agree to participate in the study program and provide written and informed consent.~Exclusion Criteria:~1. Subjects who received Entereg preoperatively.~2. Subjects that have taken therapeutic doses of opioids for more than 7 days immediately prior to surgery.~3. Subjects with severe hepatic impairment.~4. Subjects with end-stage renal disease.~5. Subjects who are pregnant.~6. Subjects who were diagnosed with a complete small bowel obstruction preoperatively.~7. Subjects with a medical condition that may interfere with the use of the study medication Entereg.~8. Subjects who have a condition or general disability or infirmity that in the opinion of the investigator precludes further participation in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Alvimopan group (Type: EXPERIMENTAL): In addition to standard postoperative care, patients randomized to the study group will be given 12mg of alvimopan orally twice a day, from the time of diagnosis of postoperative ileus to the time of return of bowel function or for 5 days.
- Control Group (Type: OTHER): Patients randomized to the control group receive standard postoperative care which includes but is not limited to NPO status, IV fluid rehydration, and nasogastric decompression.

Based on this trial design, predict the completion outcome and termination type (if applicable).